MedTrace Logo

Effects of an Activity Control System in Patients With Diabetes: a Randomized Controlled Trial

NCT04380844 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-12-24

No results posted yet for this study

Summary

Using a smart device (Beprevent) to monitor activities of daily living improves the lifestyle of patients with DM2

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

Beprevent

10 will become part of the intervention group. At first, they are given a series of questionnaires, later (1 day later) we stay at their home to install the Beprevent device, which will remain in their home for a period of two weeks, to finish and once the device of your home, we will proceed to pass the same questionnaires as at the beginning of the test, in order to compare results.

Sponsors & Collaborators

  • Universidad Católica San Antonio de Murcia

    collaborator OTHER

  • Maimónides Biomedical Research Institute of Córdoba

    lead OTHER

Principal Investigators

  • Jesús Gómez Lama, MD · Maimónides Biomedical Research Institute of Córdoba

  • David Pérez Cruzado · Universidad Católica San Antonio de Murcia

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2021-05-01
Completion
2021-11-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04380844 on ClinicalTrials.gov